Vertex Pharmaceuticals Inc. (VRTX)

Index: Nasdaq 100
-1.95%
-$1.62
$81.55
21:15 17/01/17
$81.55
21:15 17/01/17
DAILY VARIATION
-1.95%
-$1.62
VOLUME
1,439,882
DATA
52 Week High
$102.83
52 Week Low
$72.02
Shares Issued
247.78m
Market Cap
$20,206.35m
RiskGrade
186
Beta
1.76
MENU

Vertex Pharmaceuticals Inc. Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -45.2% 17.0%
ROCE 0.0%
Latest F'cast
P/E -36.0 4,097.0
PEG 0.0 0.2
Pr/Revenue 20.0 9.4
Pr/Book 18.8
Latest F'cast
Revenue 77.9% 0.0%
PBT 0.0% n/a
EPS 0.0% 0.0%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 1,527.04 -12.38 -50.00¢ -83.8 0.0 n/a n/a 0.0%
2013-12-31 1,211.97 -626.04 -198.00¢ -37.5 0.0 n/a n/a 0.0%
2014-12-31 580.41 -734.88 -314.00¢ -37.8 0.0 n/a n/a 0.0%
2015-12-31 1,032.34 -557.80 -231.00¢ -54.5 0.0 n/a n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2016-12-31 1,695.26 -70.84 78.23c 10,396.2 n/a 0% 0.00c 0.0%
2017-12-31 2,119.58 361.38 200.19c 4,097.0 26.3 156% 0.00c 0.0%
2018-12-31 2,782.98 950.51 361.37c 2,253.9 28.0 81% 0.00c 0.0%

Regulatory News

No results found

Newspaper Links

No results found